|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu B and Xie J: Identifying therapeutic
targets in gastric cancer: The current status and future direction.
Acta Biochim Biophys Sin (Shanghai). 48:90–96. 2016.PubMed/NCBI
|
|
4
|
Kimchi-Sarfaty C, Ben-Nun-Shaul O, Rund D,
Oppenheim A and Gottesman MM: In vitro-packaged SV40 pseudovirions
as highly efficient vectors for gene transfer. Hum Gene Ther.
13:299–310. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baguley BC: Multiple drug resistance
mechanisms in cancer. Mol Biotechnol. 46:308–316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thomas DM and Zalcberg JR: 5-fluorouracil:
A pharmacological paradigm in the use of cytotoxics. Clin Exp
Pharmacol Physiol. 25:887–895. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jung J: Emerging utilization of chrysin
using nanoscale modification. J Nanometer. 2016:72016.
|
|
8
|
Pal-Bhadra M, Ramaiah MJ, Reddy TL,
Krishnan A, Pushpavalli SN, Babu KS, Tiwari AK, Rao JM, Yadav JS
and Bhadra U: Plant HDAC inhibitor chrysin arrest cell growth and
induce p21WAF1 by altering chromatin of STAT response element in
A375 cells. BMC Cancer. 12:1802012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin YM, Chen CI, Hsiang YP, Hsu YC, Cheng
KC, Chien PH, Pan HL, Lu CC and Chen YJ: Chrysin attenuates cell
viability of human colorectal cancer cells through autophagy
induction unlike 5-fluorouracil/oxaliplatin. Int J Mol Sci.
19:17632018. View Article : Google Scholar
|
|
10
|
Xia Y, Lian S, Khoi PN, Yoon HJ, Joo YE,
Chay KO, Kim KK and Do Jung Y: Chrysin inhibits tumor
promoter-induced MMP-9 expression by blocking AP-1 via suppression
of ERK and JNK pathways in gastric cancer cells. PLoS One.
10:e01240072015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sawicka D, Car H, Borawska MH and
Niklinski J: The anticancer activity of propolis. Folia Histochem
Cytobiol. 50:25–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schumacher M, Hautzinger A, Rossmann A,
Holzhauser S, Popovic D, Hertrampf A, Kuntz S, Boll M and Wenzel U:
Chrysin blocks topotecan-induced apoptosis in Caco-2 cells in spite
of inhibition of ABC-transporters. Biochem Pharmacol. 80:471–479.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gyémánt N, Tanaka M, Antus S, Hohmann J,
Csuka O, Mándoky L and Molnár J: In vitro search for synergy
between flavonoids and epirubicin on multidrug-resistant cancer
cells. In vivo. 19:367–374. 2005.PubMed/NCBI
|
|
14
|
Hasan MM, Islam MS, Hoque KMF, Haque A and
Reza MA: Effect of Citrus macroptera fruit pulp juice on alteration
of caspase pathway rendering anti-proliferative activity against
Ehrlich's ascites carcinoma in mice. Toxicol Res. 35:271–277. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chou TC: Drug combination studies and
their synergy quantification using the Chou-Talalay method. Cancer
Res. 70:440–446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ittiudomrak T, Puthong S, Roytrakul S and
Chanchao C: α-Mangostin and apigenin induced cell cycle arrest and
programmed cell death in SKOV-3 ovarian cancer cells. Toxicol Res.
35:167–179. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jung J, Song DY, Hwang JJ, Park HJ, Lee
JS, Song SY, Jeong SY and Choi EK: Induction of p53-mediated
senescence is essential for the eventual anticancer therapeutic
effect of RH1. Arch Pharm Res. 42:815–823. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lim HK, Kim KM, Jeong SY, Choi EK and Jung
J: Chrysin increases the therapeutic efficacy of docetaxel and
mitigates docetaxel-induced edema. Integr Cancer Ther. 16:496–504.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Huang JM, Wang JN, Xiong XK, Yang XF
and Zou F: Combination of chrysin and cisplatin promotes the
apoptosis of Hep G2 cells by up-regulating p53. Chem Biol Interact.
232:12–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rasouli S and Zarghami N: Synergistic
growth inhibitory effects of chrysin and metformin combination on
breast cancer cells through hTERT and cyclin D1 suppression. Asian
Pac J Cancer Prev. 19:977–982. 2018.PubMed/NCBI
|
|
21
|
Tao J, Zhi X, Tian Y, Li Z, Zhu Y, Wang W,
Xie K, Tang J, Zhang X, Wang L and Xu Z: CEP55 contributes to human
gastric carcinoma by regulating cell proliferation. Tumour Biol.
35:4389–4399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsuoka T and Yashiro M: The role of
PI3K/Akt/mTOR signaling in gastric carcinoma. Cancers (Basel).
6:1441–1463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khoo BY, Chua SL and Balaram P: Apoptotic
effects of chrysin in human cancer cell lines. Int J Mol Sci.
11:2188–2199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Agarwal ML, Agarwal A, Taylor WR, Chernova
O, Sharma Y and Stark GR: A p53-dependent S-phase checkpoint helps
to protect cells from DNA damage in response to starvation for
pyrimidine nucleotides. Proc Natl Acad Sci USA. 95:14775–14780.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim EJ, Kang GJ, Kang JI, Boo HJ, Hyun JW,
Koh YS, Chang WY, Kim YR, Kwon JM, Maeng YH, et al: Over-activation
of AKT signaling leading to 5-Fluorouracil resistance in
SNU-C5/5-FU cells. Oncotarget. 9:19911–19928. 2018. View Article : Google Scholar : PubMed/NCBI
|
